Related references
Note: Only part of the references are listed.The Impact of Serial Low-dose Radon Hyperthermia Exposure on Pain, Disease Activity and Pivotal Cytokines of Bone Metabolism in Ankylosing Spondylitis - A Prospective Study
G. Dischereit et al.
AKTUELLE RHEUMATOLOGIE (2014)
Osteoporosis - Inflammatory Effects on Bone Metabolism and Fracture Risk
G. Dischereit et al.
ZEITSCHRIFT FUR ORTHOPADIE UND UNFALLCHIRURGIE (2014)
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
Ulrike Harre et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The Impact of Serial Low-Dose Radon and Hyperthermia Exposure in a Therapeutic Adit on Pivotal Cytokines of Bone Metabolism in Ankylosing Spondylitis
U. Lange et al.
PHYSIKALISCHE MEDIZIN REHABILITATIONSMEDIZIN KURORTMEDIZIN (2012)
The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis
Ingo H. Tarner et al.
CLINICAL RHEUMATOLOGY (2009)
Genetic Aspects of Osteopenia/Osteoporosis in Ankylosing Spondylitis
U. Lange et al.
ZEITSCHRIFT FUR ORTHOPADIE UND UNFALLCHIRURGIE (2009)
IL-17/Th17 targeting: On the road to prevent chronic destructive arthritis?
Erik Lubberts
CYTOKINE (2008)
Receptor activator of nuclear factor kappa B ligand and osteoprotegerin regulation of bone remodeling in health and disease
Ann E. Kearns et al.
ENDOCRINE REVIEWS (2008)
The role of receptor activator of nuclear factor-κB (RANK)/RANK ligand/osteoprotegerin:: Clinical implications
Damaris Vega et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Osteoclasts: What do they do and how do they do it?
Steven L. Teitelbaum
AMERICAN JOURNAL OF PATHOLOGY (2007)
Elevated serum levels of soluble receptor activator of nuclear factors-κB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS)
H. -R. Kim et al.
RHEUMATOLOGY (2006)
RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis
A. R. Pettit et al.
RHEUMATOLOGY (2006)
Rheumatic diseases: the effects of inflammation on bone
NC Walsh et al.
IMMUNOLOGICAL REVIEWS (2005)
Radon therapy for the treatment of rheumatic diseases -: Review and meta-analysis of controlled clinical trials
A Falkenbach et al.
RHEUMATOLOGY INTERNATIONAL (2005)
Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis - Effects on synovial inflammation, bone erosion, and cartilage destruction
J Zwerina et al.
ARTHRITIS AND RHEUMATISM (2004)
Share Paper
